Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 3
2011 3
2012 1
2013 2
2014 1
2015 3
2016 6
2017 2
2018 4
2019 5
2020 5
2021 7
2022 11
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
Patel K, Huo Y, Jao J, Powis KM, Williams PL, Kacanek D, Yee LM, Chadwick EG, Shiau S, Jacobson DL, Brummel SS, Sultan-Beyer L, Kahlert CR, Zash R, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study; Swiss Mother and Child HIV Cohort Study. Patel K, et al. N Engl J Med. 2022 Sep 1;387(9):799-809. doi: 10.1056/NEJMoa2200600. N Engl J Med. 2022. PMID: 36053505 Free PMC article.
Synthesizing the connections between environmental disturbances and zoonotic spillover.
Ellwanger JH, Fearnside PM, Ziliotto M, Valverde-Villegas JM, Veiga ABGD, Vieira GF, Bach E, Cardoso JC, Müller NFD, Lopes G, Caesar L, Kulmann-Leal B, Kaminski VL, Silveira ES, Spilki FR, Weber MN, Almeida SEM, Hora VPD, Chies JAB. Ellwanger JH, et al. Among authors: muller nfd. An Acad Bras Cienc. 2022 Sep 19;94(suppl 3):e20211530. doi: 10.1590/0001-3765202220211530. eCollection 2022. An Acad Bras Cienc. 2022. PMID: 36169531 Free article. Review.
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group; Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, et al. HIV Med. 2015 Apr;16 Suppl 1(0 1):1-9. doi: 10.1111/hiv.12227. HIV Med. 2015. PMID: 25711317 Free PMC article. No abstract available.
Determinants of HIV-1 broadly neutralizing antibody induction.
Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, Huber M, Braun DL, Hozé N, Scherrer A, Magnus C, Weber J, Uhr T, Cippa V, Thorball CW, Kuster H, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Fellay J, Regoes RR, Günthard HF, Trkola A; Swiss HIV Cohort Study. Rusert P, et al. Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187. Epub 2016 Sep 26. Nat Med. 2016. PMID: 27668936
56 results